- Home
- UUUU vs RCUS Comparison
UUUU vs RCUS Comparison
Compare UUUU & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUUU
- RCUS
- Stock Information
- Founded
- UUUU 1987
- RCUS 2015
- Country
- UUUU United States
- RCUS United States
- Employees
- UUUU N/A
- RCUS N/A
- Industry
- UUUU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- UUUU Industrials
- RCUS Health Care
- Exchange
- UUUU Nasdaq
- RCUS Nasdaq
- Market Cap
- UUUU 1.1B
- RCUS 906.4M
- IPO Year
- UUUU N/A
- RCUS 2018
- Fundamental
- Price
- UUUU $5.43
- RCUS $8.63
- Analyst Decision
- UUUU Buy
- RCUS Buy
- Analyst Count
- UUUU 2
- RCUS 10
- Target Price
- UUUU $7.75
- RCUS $23.75
- AVG Volume (30 Days)
- UUUU 13.1M
- RCUS 1.1M
- Earning Date
- UUUU 08-01-2025
- RCUS 08-07-2025
- Dividend Yield
- UUUU N/A
- RCUS N/A
- EPS Growth
- UUUU N/A
- RCUS N/A
- EPS
- UUUU N/A
- RCUS N/A
- Revenue
- UUUU $69,586,000.00
- RCUS $141,000,000.00
- Revenue This Year
- UUUU N/A
- RCUS N/A
- Revenue Next Year
- UUUU $232.36
- RCUS $28.73
- P/E Ratio
- UUUU N/A
- RCUS N/A
- Revenue Growth
- UUUU 59.09
- RCUS N/A
- 52 Week Low
- UUUU $3.20
- RCUS $6.50
- 52 Week High
- UUUU $7.47
- RCUS $18.98
- Technical
- Relative Strength Index (RSI)
- UUUU 53.86
- RCUS 44.17
- Support Level
- UUUU $5.65
- RCUS $8.75
- Resistance Level
- UUUU $6.08
- RCUS $9.35
- Average True Range (ATR)
- UUUU 0.39
- RCUS 0.62
- MACD
- UUUU -0.01
- RCUS -0.15
- Stochastic Oscillator
- UUUU 42.96
- RCUS 13.14
About UUUU Energy Fuels Inc (Canada)
Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.